Hypercholesterolemia. Pure hypercholesterolemia
Conditions
Interventions
Intervention 1: Intervention 1: The intervention group in addition to Standard Treatment (a training course in lifestyle & 10 mg Atorvastatin tablets), daily intake of 40 mg pickled capers with meals
Treatment - Drugs
Intervention 1: The intervention group in addition to Standard Treatment (a training course in lifestyle & 10 mg Atorvastatin tablets), daily intake of 40 mg pickled capers with meals for lunch and d
Intervention 2:Control group, Standard Treatment (a training course in lifestyle & 10 mg Atorvastatin tablets)
Sponsors
Vice chancellor for research, Shahed University
Eligibility
Sex/Gender
Male
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Hyperlipidemia (LDL= 100 based on Framingham criteria), sex: male, age 40 to 60 years. Exclusion criteria: Hyperlipidemia during treatment; pregnancy and lactation; CHD patient; BP = 140/90; Coagulopathies; thyroid disease; Having a particular diet, or the consumption of medicine that affects blood lipid level (e.g. OCP, corticosteroid, etc.); special illnesses that affect lipid profile (e.g. renal failure); discontinuing treatment at any stage; smoking, drug and alcohol abuse; taking medicine or doing anything that affects lipid profile 30 days prior to the study; any side effect that might stop treatment and major stress levels based on DSM IV during the study or the last three months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Low Density Lipoprotein- Cholestrol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum High Density Lipoprotein- Cholesterol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Total Cholesterol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Triglyceride Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Added at 2017-11-18: Apptetite. Timepoint: Added at 2017-11-18: Before intervention and at the end of study. Method of measurement: Added at 2017-11-18: VAS questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Glutamic Pyruvic Teransamins. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Glutamic Oxaloacetic Transaminase. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Fasting Blood Suger. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Blood Urea Nitrogen Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Creatinine Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Added at 2017-11-18: Sleep disorders. Timepoint: Added at 2017-11-18: Before intervention and at the end of study. Method of measurement: Added at 2017-11-18: Sleep questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Sardari
Shahed University
Outcome results
None listed